Ironwood Pharmaceuticals | IRWD - Kapitał Własny I Rezerwy





Kapitał Własny I Rezerwy Zmiana Data
Acadia Pharmaceuticals USD 917.27M 94.89M 2025-09
Agios Pharmaceuticals USD 1.19B 91.22M 2025-12
Akebia Therapeutics USD 32.61M 8.98M 2025-12
Almirall EUR 1.49B 24.03M 2025-12
Alnylam Pharmaceuticals USD 789.18M 555.28M 2025-12
Amarin USD 459.28M 387K 2025-12
Ardelyx USD 166.95M 12.67M 2025-12
Astellas Pharma JPY 1.83T 65.92B 2026-03
AstraZeneca USD 48.67B 2.78B 2025-12
Charles River Laboratories USD 3.16B 240.82M 2025-12
Coherus Biosciences USD 61.01M 26.76M 2025-12
Emergent BioSolutions USD 649.3M 47.9M 2023-12
Esperion Therapeutics USD -301.96M 149.4M 2025-12
Halozyme Therapeutics USD 48.81M 455.1M 2025-12
Incyte USD 5.62B 455.37M 2026-03
Ironwood Pharmaceuticals USD -264.16M 44M 2025-09
Karyopharm Therapeutics USD -292.93M 23.67M 2025-12
Lexicon Pharmaceuticals USD 107.54M 12.62M 2025-12
MacroGenics USD 55.59M 11.41M 2025-12
Moderna USD 8.65B 680M 2025-12
Myriad Genetics USD 368M 4.8M 2025-12
Pacira USD 693.11M 34.1M 2025-12
PTC Therapeutics USD -205.31M 49.56M 2025-12
Puma Biotechnology USD 115.27M 10.55M 2025-09
Sarepta Therapeutics USD 1.14B 179.5M 2025-12
Takeda JPY 7.64T 513.39B 2025-12
Ultragenyx Pharmaceutical USD 9.16M 142.13M 2025-09
Vanda Pharmaceuticals USD 327.19M 138.81M 2025-12